Literature DB >> 4365773

Rickets and the pathogenesis of impaired tubular transport of phosphate and other solutes.

C R Scriver.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4365773     DOI: 10.1016/0002-9343(74)90766-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  14 in total

1.  Hypophosphatemic rickets: easy to diagnose, difficult to treat.

Authors:  R K Garg; N Tandon
Journal:  Indian J Pediatr       Date:  1999 Nov-Dec       Impact factor: 1.967

2.  Does growth hormone influence the severity of phosphopenic rickets?

Authors:  T Bistritzer; S A Chalew; A Hanukoglu; K M Armour; P J Haney; A A Kowarski
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

3.  Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.

Authors:  M Peacock; P J Heyburn; J E Aaron
Journal:  Calcif Tissue Res       Date:  1977-05

Review 4.  The William Allan Memorial Award address: On phosphate transport and genetic screening. "Understanding backward--living forward" in human genetics.

Authors:  C R Scriver
Journal:  Am J Hum Genet       Date:  1979-05       Impact factor: 11.025

5.  The pathophysiology of bone and joint disease.

Authors:  S L Teitelbaum; P G Bullough
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

6.  Impaired phosphorus conservation and 1,25 dihydroxyvitamin D generation during phosphorus deprivation in familial hypophosphatemic rickets.

Authors:  K L Insogna; A E Broadus; J M Gertner
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

Review 7.  X-linked hypophosphataemia: a homologous phenotype in humans and mice with unusual organ-specific gene dosage.

Authors:  C R Scriver; H S Tenenhouse
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

8.  Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.

Authors:  M K Drezner; K W Lyles; M R Haussler; J M Harrelson
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  Skeletal manifestations of moderate phosphate diabetes.

Authors:  M Laroche; J Arlet; J L Ader; D Durand; T Tran-Van; B Mazières
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

10.  Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.

Authors:  R M Harrell; K W Lyles; J M Harrelson; N E Friedman; M K Drezner
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.